AbCellera Biologics Inc. (ABCL) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $75.13M | +160.6% |
| 2024 | $28.83M | -24.2% |
| 2023 | $38.02M | -92.2% |
| 2022 | $485.42M | +29.4% |
| 2021 | $375.20M | +60.9% |
| 2020 | $233.16M | +1907.9% |
| 2019 | $11.61M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $75.13M | +160.6% |
| 2024 | $28.83M | -24.2% |
| 2023 | $38.02M | -92.2% |
| 2022 | $485.42M | +29.4% |
| 2021 | $375.20M | +60.9% |
| 2020 | $233.16M | +1907.9% |
| 2019 | $11.61M | — |